- Home
- WISA vs APM Comparison
WISA vs APM Comparison
Compare WISA & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WISA
- APM
- Stock Information
- Founded
- WISA 2010
- APM 2010
- Country
- WISA United States
- APM United Kingdom
- Employees
- WISA N/A
- APM N/A
- Industry
- WISA Semiconductors
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- WISA Technology
- APM Health Care
- Exchange
- WISA Nasdaq
- APM Nasdaq
- Market Cap
- WISA 9.9M
- APM 9.8M
- IPO Year
- WISA 2018
- APM 2018
- Fundamental
- Price
- WISA $2.02
- APM $0.73
- Analyst Decision
- WISA Buy
- APM
- Analyst Count
- WISA 2
- APM 0
- Target Price
- WISA $14.00
- APM N/A
- AVG Volume (30 Days)
- WISA 600.2K
- APM 25.7K
- Earning Date
- WISA 11-15-2024
- APM 12-20-2024
- Dividend Yield
- WISA N/A
- APM N/A
- EPS Growth
- WISA N/A
- APM N/A
- EPS
- WISA N/A
- APM N/A
- Revenue
- WISA $1,789,000.00
- APM $431,378.00
- Revenue This Year
- WISA N/A
- APM $157,729.10
- Revenue Next Year
- WISA $207.69
- APM N/A
- P/E Ratio
- WISA N/A
- APM N/A
- Revenue Growth
- WISA N/A
- APM N/A
- 52 Week Low
- WISA $1.15
- APM $1.09
- 52 Week High
- WISA $37.50
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- WISA 54.83
- APM 16.33
- Support Level
- WISA $1.73
- APM $1.21
- Resistance Level
- WISA $2.16
- APM $1.37
- Average True Range (ATR)
- WISA 0.12
- APM 0.11
- MACD
- WISA 0.01
- APM -0.02
- Stochastic Oscillator
- WISA 64.29
- APM 1.33
About WISA WiSA Technologies Inc.
WiSA Technologies Inc is a provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems through the sale of module components to audio companies as well as audio products to resellers and consumers.. The company works with consumer electronics companies, technology providers, retailers, and ecosystem partners to make immersive audio an enjoyable experience. The company has a geographic presence in Asia Pacific, North America, Europe and, other.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.